Exploring the feasibility and utility of exome‐scale tumour sequencing in a clinical setting
Technology has progressed from single gene panel to large‐scale genomic sequencing. This is raising expectations from clinicians and patients alike. The utility and performance of this technology in a clinical setting needs to be evaluated.
No Supplementary Data
No Article Media